Jennison Associates LLC Verona Pharma PLC Transaction History
Jennison Associates LLC
- $160 Billion
- Q3 2024
A detailed history of Jennison Associates LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Jennison Associates LLC holds 1,740,886 shares of VRNA stock, worth $93.1 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,740,886
Previous 1,128,032
54.33%
Holding current value
$93.1 Million
Previous $16.3 Million
207.06%
% of portfolio
0.03%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding VRNA
# of Institutions
169Shares Held
68.7MCall Options Held
704KPut Options Held
685K-
Perceptive Advisors LLC New York, NY6.32MShares$338 Million4.75% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$299 Million12.27% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.01MShares$268 Million2.01% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx4.22MShares$226 Million2.52% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$190 Million14.95% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $3.26B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...